Global Defibrillators Market - Strategic Insights and Forecasts (2026-2031)

The Global Defibrillators market is forecast to grow at a CAGR of 5.0%, reaching USD 23.10 billion in 2031 from USD 18.14 billion in 2026.

Defibrillators Market Trends:

The defibrillator is a medical device that is used to send an electrical shock to the heart for the restoration of the heartbeat. The equipment prevents or corrects an uneven heartbeat, which could lead to sudden cardiac arrest. The prevalence of heart disease and bypass surgeries is showing a constant rise, coupled with the aging population. For instance, according to the World Health Organization, in 2019, the number of deaths recorded due to cardiovascular disease stood at 17.9 million, which represented 32% of all global deaths.

Furthermore, according to the Centers for Disease Control and Prevention, in 2020, in the United States, the number of deaths recorded due to heart disease stood at 697,000. Moreover, according to Eurostat, in 2020, 38,900 heart bypass surgeries were conducted in Germany, which was more than double the number of surgeries conducted in any of the EU’s member states. Owing to such a high death count due to heart diseases and an increase in bypass surgeries, the demand and usage of defibrillators in such instances are also projected to increase in the future, thereby boosting the global defibrillator market growth during the forecast period.

The global defibrillator market is segmented based on its type into automated external defibrillators (AED), implantable cardioverter defibrillators (ICD), and wearable cardio defibrillators (WCD). The automated external defibrillator is expected to grow at a relatively higher rate during the forecast period. They are highly applicable during the treatment of sudden cardiac arrest, as the combination of the equipment with CPR improves the resuscitation chances.

The equipment is portable and can automatically analyze the heart rate of an individual experiencing cardiac arrest. Owing to its high-performance features coupled with growing cases of heart failure, the demand for automated external defibrillators is projected to increase, thereby improving the segment growth as well as the global defibrillators market growth during the forecast period.

Defibrillators Market Drivers:

• Rising prevalence of sudden cardiac arrest is expected to drive the defibrillator market.

The defibrillator market is expected to grow due to the increasing prevalence of out-of-hospital cardiac arrests and the comfort offered by external defibrillators. Government regulations in developed nations are driving the installation of external defibrillators in public places, with wearable defibrillators like LifeVest being launched in certain regions.

The safety of external defibrillators compared to implantable ones is projected to increase adoption. Sudden cardiac arrest is a life-threatening condition that requires immediate intervention, often involving defibrillation. The time-critical nature of sudden cardiac arrest necessitates prompt and time-critical intervention, leading to the demand for accessible and strategically placed defibrillators. Public access defibrillation programs aim to make AEDs available in public spaces, increasing the chances of early defibrillation.

Healthcare settings are prioritizing early defibrillation as part of the chain of survival in managing sudden cardiac arrest cases. Increased training and awareness initiatives, such as basic life support and cardiopulmonary resuscitation training, contribute to increased awareness about the importance of defibrillation in saving lives during sudden cardiac arrest events.

• The favorable government initiatives and investments are creating a surge in demand for defibrillators.

Defibrillators provide the urgent assistance required to maintain the heartbeat of an individual during a sudden cardiac arrest situation, which can occur anywhere. Realizing the growing threat of heart disease, various initiatives, schemes, and investments have been implemented by the governing authorities to tackle such health-related issues. For instance, in May 2022, the Delhi government announced its plans to install automated external defibrillators in public places such as bus stops, railway stations, and marketplaces to provide quick medical assistance to people who suffer cardiac arrest in public places. Additionally, in March 2021, the Rankin government announced investments of US$700,000 to install automated external defibrillators in all public schools in Nova Scotia.

Furthermore, in February 2022, the Welsh government announced investments of US$676.8 million to increase the availability of defibrillators in public organizations, community groups, and sports grounds to improve the survival rate of people who suffer sudden cardiac arrest outside hospitals. Such favorable investments and plans to increase access to defibrillators in public places will create a surge in the demand and usage of the equipment, thereby boosting their market growth at a global level during the forecast period.

Defibrillators Market Developments:

• March 2026: Medtronic received FDA approval for the OmniaSecure™ defibrillation lead supporting left bundle branch area pacing, becoming the first lumenless defibrillation lead approved for conduction system pacing applications.

• March 2026: HeartHero submitted FDA Premarket Approval application for Elliot AED, a connected automated external defibrillator designed specifically for home and community cardiac emergency response accessibility.

• February 2026: ZOLL Medical announced EU MDR approval for its Zenix® monitor/defibrillator, introducing advanced touchscreen workflows, intelligent monitoring features, and integrated emergency response capabilities for hospital and EMS environments.

• January 2026: Kestra Medical Technologies partnered with Biobeat Technologies to expand diagnostic monitoring capabilities for ASSURE® wearable cardioverter defibrillator patients through continuous cuffless blood pressure and recovery monitoring integration.

• January 2026: AliveCor received FDA clearance expanding Kardia 12L ECG System capabilities with five additional AI-powered cardiac determinations, strengthening portable cardiac diagnostics and emergency cardiac monitoring applications.

Defibrillators Market Scope: 

Defibrillators Market Segmentation:

• By Type

  • Automated External Defibrillator (AED)

  • Implantable Cardioverter-Defibrillator (ICD)

  • Wearable Cardio Defibrillator (WCD)

• By End-User

  • Hospitals & Clinics

  • Ambulatory Surgical Center

  • Others

• By Geography

  • North America

    • USA

    • Canada

    • Mexico

  • South America

    • Brazil

    • Argentina

    • Others

  • Europe

    • Germany

    • France

    • United Kingdom

    • Italy

    • Spain

    • Others

  • Middle East and Africa

    • Saudi Arabia

    • Israel

    • United Arab Emirates

    • Others

  • Asia Pacific

    • China

    • Japan

    • South Korea

    • India

    • Australia

    • Indonesia

    • Thailand

    • Taiwan

    • Others